Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: 6-Chloro-9-tetrahydro-2-pyranyl-purine
CAS Number: 7306-68-5
Molecular Weight:  238.6761
Molecular Formula:  C10H11ClN4O
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.